Risk estimation for the next generation of prevention programmes for cervical cancer

This publication has 11 references indexed in Scilit:

• Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women
  Published by Elsevier ,2009
• HPV Screening for Cervical Cancer in Rural India
  New England Journal of Medicine, 2009
• Human Papillomavirus mRNA and p16 Detection as Biomarkers for the Improved Diagnosis of Cervical Neoplasia
  Cancer Epidemiology, Biomarkers & Prevention, 2008
• A new HPV-DNA test for cervical-cancer screening in developing regions: a cross-sectional study of clinical accuracy in rural China
  The Lancet Oncology, 2008
• New Technologies in Cervical Cancer Screening
  Vaccine, 2008
• 2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests
  Published by Elsevier ,2007
• 2006 consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ
  American Journal of Obstetrics and Gynecology, 2007
• Risk assessment to guide the prevention of cervical cancer
  American Journal of Obstetrics and Gynecology, 2007
• Human papillomavirus and cervical cancer
  The Lancet, 2007
• Quadrivalent Vaccine against Human Papillomavirus to Prevent High-Grade Cervical Lesions
  New England Journal of Medicine, 2007